Algunos de estos medicamentos han demostrado beneficios cardiovasculares especficos: liraglutida, semaglutida inyectable y dulaglutida reducen eventos cardiovasculares en pacientes con diabetes tipo 2 y enfermedad cardiovascular
Puede sonar demasiado bueno para ser verdad, pero es lo que una clase de medicamentos (agonistas del receptor GLP-1), como Wegovy y Ozempic, pueden hacer
Nutritional deficiencies: Prolonged vomiting and the inability to eat normally during episodes can deprive the body of vital nutrients, further impacting health
Reduced Cravings: These medications can also influence the brains reward system, potentially reducing cravings for high-calorie foods [1]
Both deliver the same molecule but differ in absorption, dosing schedule, and convenience
People on other medications Certain medications can accelerate or impede semaglutide effects